|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Profit (loss) [abstract] | |||||
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research and development expense | |||||
| Sales and marketing expense | |||||
| General and administrative expense | |||||
| Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9 | |||||
| Other gains (losses) | |||||
| Profit (loss) from operating activities | |||||
| Finance income | |||||
| Finance costs | |||||
| Gains (losses) on net monetary position | |||||
| Other results | |||||
| Profit (loss) before tax | |||||
| Tax income (expense) | |||||
| Profit (loss) | |||||
| Profit (loss), attributable to [abstract] | |||||
| Profit (loss), attributable to owners of parent | |||||
| Profit (loss), attributable to non-controlling interests | |||||
| Earnings per share [abstract] | |||||
| Basic earnings (loss) per share | |||||
| Diluted earnings (loss) per share | |||||
| Other comprehensive income [abstract] | |||||
| Exchange difference on translation on foreign operations | |||||
| Total other comprehensive income | |||||
| Total Comprehensive Income for the year | |||||
| Comprehensive income attributable to [abstract] | |||||
| Owners of the Group | |||||
| Non-controlling interest |
Loading...
